Month: October 2016

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES HOW HTA BODIES CAN CONSIDER THE VOICE OF PATIENTS WITH RARE DISEASES

Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)  led an interesting discussion session this afternoon entitled, From Testimonials to Qualitative Research Embedded in Clinical Trials: How Do Health Technology Assessment Bodies Consider the Voice of Rare

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES NEW APPROACHES TO SURVIVAL MODELING IN ONCOLOGY

Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this afternoon on New Approaches to Survival Modeling in Oncology at the Society’s 19th Annual European Congress in Vienna, Austria. 

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES EUROPEAN COOPERATION IN HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)  facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in

Posted in Announcements, ISPOR News & Press Tagged with: , ,

PLENARY 1 OF ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES SYNERGIES IN HEALTH CARE

Building Collaboration Between Regulators and Health Technology Assessment Bodies  Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened its 19th Annual European Congress in Vienna, Austria this morning with the first plenary session, What Synergies Could

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS TO FOCUS ON MANAGING ACCESS TO MEDICAL INNOVATION

Congress Scheduled for 29 October-2 November 2016 in Vienna Princeton, NJ—October 17, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced confirmation of the scientific sessions for its 19th Annual European Congress that will begin next week, 29 October-2

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ACCOUNTING FOR FUTURE PRICE REDUCTIONS CAUSED BY INCREASING ADOPTION OF MEDICAL DEVICES: IMPACT ON HTAs

Future Changes in Price and Uptake Affect Cost-Effectiveness Results  Princeton, NJ—October 10, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a report detailing a new modeling approach that explores the health technology assessment (HTA)

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR TASK FORCE PROVIDES RECOMMENDATIONS ON THE COLLECTION OF HEALTH-STATE UTILITY DATA IN CLINICAL STUDIES

Five Areas of Guidance Enable Optimum Health-State Utility Measurement  Princeton, NJ—October 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Good Practices for Outcome Research—Measurement of Health-State Utility Values for Economic Models in Clinical Studies—has published

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: ,

ISPOR’S INITIATIVE ON US VALUE ASSESSMENT FRAMEWORKS CONFERENCE DRAWS KEY HEALTH CARE STAKEHOLDERS AND THOUGHT LEADERS

Washington, DC Event Was Designed to Invite Stakeholder Input  Princeton, NJ—October 3, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its Initiative on US Value Assessment Frameworks Stakeholder Conference, in Washington, DC, USA on September 23, 2016.

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,